RCUS   $14.33  -1.98% Market Open

Arcus Biosciences Inc
Total Cash 969.00M
totalCashPerShare 10.599
EBITDA -264.00M
Total Debt 31.00M
quickRatio 5.035
currentRatio 5.136
Total Revenue 247.00M
debtToEquity 4.882
Revenue/Share 3.021
ROA -0.14183
ROE -0.41465
grossProfits
freeCashflow -95.88M
operatingCashflow -247.00M
earningsGrowth
revenueGrowth 0.345
grossMargins -0.38462
ebitdaMargins -1.06883
operatingMargins -2.71795
profitMargins -1.0081
enterpriseValue 459.93M
forwardPE -3.8272505
floatShares 51.39M
sharesOutstanding 91.43M
sharesShort 6.34M
sharesShortPriorMonth 6.90M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.41%
heldPercentInstitutions 0.58%
Short Ratio help_outline 9.97%
shortPercentOfFloat 0.14%
impliedSharesOutstanding
bookValue 6.955
Price To Book help_outline 2.26
earningsQuarterlyGrowth
netIncomeToCommon -249.00M
trailingEps -3.11%
forwardEps -4.11%
enterpriseToEbitda -1.74
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.06 3Q 2024
institutionsCount 268
lastUpdated Nov. 7, 2024, 2:48 a.m.